Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jeffrey Senfield et al. JACEP 2017;3:

Published byΛαύρα Παπάγος Modified over 5 years ago

Similar presentations

Presentation on theme: "Jeffrey Senfield et al. JACEP 2017;3:"— Presentation transcript:

1 Jeffrey Senfield et al. JACEP 2017;3:818-826
Time to HF Hospitalization or Death by Randomization With the PR Interval Dichotomized at 180 ms Composite endpoint for time to heart failure hospitalization or death for PR ≤180 ms and PR >180 ms. There was no statistical difference in the interaction p value between the 2 groups (p = 0.33). CRT OFF = cardiac resynchronization therapy control group; CRT ON = group actively on cardiac resynchronization therapy; HF = heart failure; HR = hazard ratio. Jeffrey Senfield et al. JACEP 2017;3: 2017 American College of Cardiology Foundation

Download ppt "Jeffrey Senfield et al. JACEP 2017;3:"

Similar presentations

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Marwan Badri et al. JACEP 2015;1:

Marwan Badri et al. JACEP 2015;1:
Konstantinos C. Siontis et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
David D. Berg et al. JACC 2018;71:

David D. Berg et al. JACC 2018;71:
Dileep Raman et al. JACEP 2017;3:

Dileep Raman et al. JACEP 2017;3:
Thomas C. Crawford et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;3:
Thomas C. Crawford et al. JACEP 2017;j.jacep

Thomas C. Crawford et al. JACEP 2017;j.jacep
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:
Belinda Gray et al. JCHF 2013;1:

Belinda Gray et al. JCHF 2013;1:
David F. Katz et al. JACEP 2016;j.jacep

David F. Katz et al. JACEP 2016;j.jacep
Simon W. Rabkin et al. JACEP 2017;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep
Mintu P. Turakhia et al. JACEP 2016;2:

Mintu P. Turakhia et al. JACEP 2016;2:
Simon W. Rabkin et al. JACEP 2017;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep
Wesley T. O’Neal et al. JACEP 2016;2:

Wesley T. O’Neal et al. JACEP 2016;2:
Muhammad Shahreyar et al. JACEP 2016;j.jacep

Muhammad Shahreyar et al. JACEP 2016;j.jacep
Simon W. Rabkin et al. JACEP 2017;3:

Simon W. Rabkin et al. JACEP 2017;3:

Similar presentations

Ads by Google